Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Treatment

Registeration For The American Association Of Kidney Patients' National Convention Now Open!
Registration for the American Association of Kidney Patients" (AAKP) 36th Annual National Convention is now open. The Convention takes place Sept. 3-5 at the Hyatt Regency Denver in Denver, Colo. The Annual Convention provides patients, family members and health care professionals the opportunity to learn about important issue affecting kidney patients. During this three-day event, attendees participate in educational sessions for those with chronic kidney disease (CKD) to long-term dialysis and transplant patients. Participants also learn about various treatments for each stage of kidney disease.
generic viagra online
HydroCision Introduces The "Walk In/Walk Out" Option For Treatment Of Herniated Discs
HydroCision Inc. announced the launch of its new SpineJet® Percutaneous Access Set for use in herniated disc procedures using its novel cutting-with-water fluidjet technology. "These instruments will assist the company to more quickly capitalize on the double digit growth of the minimally invasive percutaneous discectomy market," says Doug Daniels. "A large driver of procedural growth has been patients who seek out surgeons who perform minimally invasive procedures to reduce down time from work in these tough economic times. This has led to rapid adoption of this new and evolving technique for the treatment of lower back pain by a growing number of neurosurgeons, orthopedic surgeons and interventional pain physicians. This trend has created the need for new instruments that can work through very small incisions."
News of the day
UK Travellers Could Pay The Price For Paradise - More Brits Considering Long Haul Trips But Ignoring The Threat Of Malaria
Brits taking advantage of last-minute credit crunch deals to tropical destinations could be seriously risking their health, according to a survey of over 1,000 UK travellers.1
Mental Health

Survivors Of Childhood Central Nervous System Cancer Face Persistent Risks As Adults

Long-term survivors of childhood central nervous system (CNS) malignancies remain at risk for death and are at increasing risk for developing subsequent cancers and chronic medical conditions over time, according to a new study published online June 17 in the JNCI. It was known that survivors of childhood CNS malignancies faced long-term side effects, but this large, 30-year study is one of the first to examine their long-term risks of subsequent cancers and debilitating medical conditions, as well as sociodemographic outcomes into adulthood. To address these risks, Gregory Armstrong, M.D., M.S.C.E., at St. Jude Children"s Research Hospital in Memphis, Tenn., and colleagues collected information on treatment, mortality, chronic medical conditions, and neurocognitive functioning from patients who had been diagnosed between 1970 and 1986 within the Childhood Cancer Survivor Study and had survived for 5 or more years after diagnosis. The researchers found that these survivors had a risk of death that was 13 times that of the general population. Recurrence or progression of primary disease was the most common cause of death in the first 30 years after diagnosis. The risk of developing a subsequent cancer was associated with radiation exposure during initial treatment, and this risk continues to increase over time in this population. For patients with certain tumor types, increased radiation therapy was also associated with neurocognitive impairment. Radiation of the frontal/temporal lobes was associated with lower levels of employment and marriage. "Continued follow-up will help determine temporal patterns in incidence and late effects as this cohort ages," the authors write. "Modern therapeutic regimens that increasingly use chemotherapy to reduce [radiation therapy] dose or use limited [radiation therapy] fields will likely improve long-term outcomes and minimize the risk of adverse late effects." Author: Summer Freeman Steve Graff Journal of the National Cancer Institute


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009